2023
DOI: 10.1111/hepr.13982
|View full text |Cite
|
Sign up to set email alerts
|

Effects of entecavir and tenofovir alafenamide fumarate treatment on renal function in Japanese elderly patients with chronic hepatitis B

Misako Tanaka,
Takemi Akahane,
Hideto Kawaratani
et al.

Abstract: AimEntecavir (ETV) and tenofovir alafenamide fumarate (TAF) are considered safe nucleos(t)ide analogs (NA) for the kidney. This study aimed to investigate the long‐term effects of ETV or TAF on renal function in elderly patients with chronic hepatitis B (CHB) in Japan.MethodsThe study included 246 CHB patients treated with ETV (184 patients) or TAF (62 patients) for at least 2 years. These patients were divided into two groups: those <65 years of age (130 patients) and those ≥65 years of age (116 patients).… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 35 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?